vs

Side-by-side financial comparison of Amer Sports, Inc. (AS) and Invesco (IVZ). Click either name above to swap in a different company.

Invesco is the larger business by last-quarter revenue ($1.7B vs $1.1B, roughly 1.6× Amer Sports, Inc.). Amer Sports, Inc. runs the higher net margin — 1.8% vs -58.9%, a 60.7% gap on every dollar of revenue. Invesco produced more free cash flow last quarter ($432.2M vs $92.2M).

Amer Sports, Inc. is a Finnish multinational sporting equipment division based in Helsinki, Finland. Established in 1950 as an industrial conglomerate with interests as diverse as tobacco trading, ship owning and publishing, Amer has gradually evolved into a multinational firm devoted to the production and marketing of sporting goods. The company employs over 9,700 people. Since 2018, Amer has been a subsidiary of Chinese retail conglomerate Anta Sports.

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

AS vs IVZ — Head-to-Head

Bigger by revenue
IVZ
IVZ
1.6× larger
IVZ
$1.7B
$1.1B
AS
Higher net margin
AS
AS
60.7% more per $
AS
1.8%
-58.9%
IVZ
More free cash flow
IVZ
IVZ
$340.0M more FCF
IVZ
$432.2M
$92.2M
AS

Income Statement — Q1 FY2024 vs Q4 FY2025

Metric
AS
AS
IVZ
IVZ
Revenue
$1.1B
$1.7B
Net Profit
$19.0M
$-995.9M
Gross Margin
52.8%
Operating Margin
12.4%
-86.2%
Net Margin
1.8%
-58.9%
Revenue YoY
6.2%
Net Profit YoY
-575.8%
EPS (diluted)
$0.05
$-2.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AS
AS
IVZ
IVZ
Q4 25
$1.7B
Q3 25
$1.6B
Q2 25
$1.5B
Q1 25
$1.5B
Q4 24
$1.6B
Q3 24
$1.5B
Q2 24
$1.5B
Q1 24
$1.1B
$1.5B
Net Profit
AS
AS
IVZ
IVZ
Q4 25
$-995.9M
Q3 25
$356.4M
Q2 25
$197.4M
Q1 25
$171.1M
Q4 24
$209.3M
Q3 24
$55.0M
Q2 24
$132.2M
Q1 24
$19.0M
$141.5M
Gross Margin
AS
AS
IVZ
IVZ
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
52.8%
Operating Margin
AS
AS
IVZ
IVZ
Q4 25
-86.2%
Q3 25
16.5%
Q2 25
14.1%
Q1 25
18.1%
Q4 24
19.6%
Q3 24
6.6%
Q2 24
13.9%
Q1 24
12.4%
14.4%
Net Margin
AS
AS
IVZ
IVZ
Q4 25
-58.9%
Q3 25
21.7%
Q2 25
13.0%
Q1 25
11.2%
Q4 24
13.1%
Q3 24
3.6%
Q2 24
8.9%
Q1 24
1.8%
9.6%
EPS (diluted)
AS
AS
IVZ
IVZ
Q4 25
$-2.61
Q3 25
$0.66
Q2 25
$-0.03
Q1 25
$0.38
Q4 24
$0.46
Q3 24
$0.12
Q2 24
$0.29
Q1 24
$0.05
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AS
AS
IVZ
IVZ
Cash + ST InvestmentsLiquidity on hand
$1.0B
Total DebtLower is stronger
$1.8B
Stockholders' EquityBook value
$12.2B
Total Assets
$27.1B
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AS
AS
IVZ
IVZ
Q4 25
$1.0B
Q3 25
$973.1M
Q2 25
$922.7M
Q1 25
$821.7M
Q4 24
$986.5M
Q3 24
$1.0B
Q2 24
$878.5M
Q1 24
$895.7M
Total Debt
AS
AS
IVZ
IVZ
Q4 25
$1.8B
Q3 25
$1.6B
Q2 25
$1.9B
Q1 25
$964.8M
Q4 24
$890.6M
Q3 24
$890.3M
Q2 24
$890.1M
Q1 24
$1.3B
Stockholders' Equity
AS
AS
IVZ
IVZ
Q4 25
$12.2B
Q3 25
$14.0B
Q2 25
$13.9B
Q1 25
$14.7B
Q4 24
$14.6B
Q3 24
$14.8B
Q2 24
$14.6B
Q1 24
$14.6B
Total Assets
AS
AS
IVZ
IVZ
Q4 25
$27.1B
Q3 25
$28.4B
Q2 25
$28.5B
Q1 25
$28.1B
Q4 24
$27.0B
Q3 24
$27.5B
Q2 24
$27.2B
Q1 24
$28.1B
Debt / Equity
AS
AS
IVZ
IVZ
Q4 25
0.15×
Q3 25
0.12×
Q2 25
0.14×
Q1 25
0.07×
Q4 24
0.06×
Q3 24
0.06×
Q2 24
0.06×
Q1 24
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AS
AS
IVZ
IVZ
Operating Cash FlowLast quarter
$114.3M
$455.8M
Free Cash FlowOCF − Capex
$92.2M
$432.2M
FCF MarginFCF / Revenue
8.8%
25.5%
Capex IntensityCapex / Revenue
2.1%
1.4%
Cash ConversionOCF / Net Profit
6.02×
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AS
AS
IVZ
IVZ
Q4 25
$455.8M
Q3 25
$606.2M
Q2 25
$547.9M
Q1 25
$-84.6M
Q4 24
$316.9M
Q3 24
$438.4M
Q2 24
$489.1M
Q1 24
$114.3M
$-54.4M
Free Cash Flow
AS
AS
IVZ
IVZ
Q4 25
$432.2M
Q3 25
$586.4M
Q2 25
$530.4M
Q1 25
$-108.0M
Q4 24
$309.9M
Q3 24
$410.0M
Q2 24
$462.4M
Q1 24
$92.2M
$-75.4M
FCF Margin
AS
AS
IVZ
IVZ
Q4 25
25.5%
Q3 25
35.7%
Q2 25
35.0%
Q1 25
-7.1%
Q4 24
19.5%
Q3 24
27.1%
Q2 24
31.2%
Q1 24
8.8%
-5.1%
Capex Intensity
AS
AS
IVZ
IVZ
Q4 25
1.4%
Q3 25
1.2%
Q2 25
1.2%
Q1 25
1.5%
Q4 24
0.4%
Q3 24
1.9%
Q2 24
1.8%
Q1 24
2.1%
1.4%
Cash Conversion
AS
AS
IVZ
IVZ
Q4 25
Q3 25
1.70×
Q2 25
2.78×
Q1 25
-0.49×
Q4 24
1.51×
Q3 24
7.97×
Q2 24
3.70×
Q1 24
6.02×
-0.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AS
AS

Americas2$409.6M39%
EMEA1$356.9M34%
Greater China3$205.6M20%
Asia Pacific4$78.2M7%

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

Related Comparisons